Otitis Media

Study for Prevention of Pediatric Ear Infections Initiated

Published in TB and Outbreaks Week, February 8th, 1999

Neose Technologies Inc., Horsham, Pennsylvania, announced that it has initiated a Phase II clinical trial of NE-1530 for the prevention of pediatric middle ear infections, or otitis media.

The Finnish National Public Health Institute in Helsinki, Finland, conducts the study in 500 children. The double-blind, placebo-controlled trial is designed to evaluate the effectiveness and safety of multiple intranasal doses of NE-1530 in the prevention of pediatric ear infections during a three-month course of treatment.

The study also evaluates changes in colonization of the bacteria that are primarily responsible for pediatric ear infections. Phase I...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (1999-02-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry